Synonyms: | |
Status: | Phase 2 |
Entry Type: | Small molecule |
Molecule Category: | UNKNOWN |
UNII: | 1L1V1K2M4V |
InChI Key | ZJXIUGNEAIHSBI-IBGZPJMESA-N |
---|---|
Smile | |
InChI |
|
Property Name | Value |
---|---|
Molecular Formula | C26H24FN3O3S |
Molecular Weight | 477.56 |
AlogP | 5.43 |
Hydrogen Bond Acceptor | 5.0 |
Hydrogen Bond Donor | 1.0 |
Number of Rotational Bond | 5.0 |
Polar Surface Area | 75.44 |
Molecular species | NEUTRAL |
Aromatic Rings | 4.0 |
Heavy Atoms | 34.0 |
Action | Mechanism of Action | Reference |
---|---|---|
ANTAGONIST | Orexin receptor 1 antagonist | PubMed |
Targets | EC50(nM) | IC50(nM) | Kd(nM) | Ki(nM) | Inhibition(%) | |
---|---|---|---|---|---|---|
Membrane receptor
Family A G protein-coupled receptor
Peptide receptor (family A GPCR)
Short peptide receptor (family A GPCR)
Orexin receptor
|
- | - | - | 0-9 | - |
Mesh Heading | Maximum Phase | Mesh ID | Reference |
---|---|---|---|
Sleep Initiation and Maintenance Disorders | 2 | D007319 | ClinicalTrials |
Sleep Wake Disorders | 1 | D012893 | ClinicalTrials |
Resources | Reference |
---|---|
CAS NUMBER | 380899-24-1 |
ChEMBL | CHEMBL1272307 |
DrugBank | DB14822 |
EPA CompTox | DTXSID90191491 |
FDA SRS | 1L1V1K2M4V |
Guide to Pharmacology | 4461 |
PubChem | 25195495 |
SureChEMBL | SCHEMBL8045969 |